What I have: semaglutide · sterile water for injection.
I am trying to do this correctly the first time rather than learn it by getting it wrong.
I have already made one mistake here that cost me a vial, so I am being deliberately careful.
What would you do, and what would you check afterwards?
Start with the regulatory basis, because compounding is permitted under specific conditions and those conditions are the whole subject.
Additives are the other divergence. Preparations combining an active with vitamins or other agents are not equivalent to the approved product and have not been studied in that combination.
Salt forms matter: a compounded preparation using a different salt from the approved product is not the same active moiety, and that has been the specific object of regulatory warnings.
Beyond-use dating for compounded sterile preparations is governed by published standards keyed to the compounding environment.
Nothing here is medical advice.
The framework is jurisdiction-specific. Check yours rather than a general answer.
edited 16 Dec 2025 by ilaria_bertone — reworded for clarity after a comment
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsAnswering this needs the jurisdiction, since the framework differs substantially between countries and even between states.
Facility quality varies enormously and is the practical determinant of what you receive. The relevant questions are about sterility assurance, potency testing and beyond-use dating.
Ask for the certificate of analysis on the compounded lot. A serious facility will have one; the request itself is informative.
Facility quality is the dominant variable and cannot be assessed from a website.
Ask for the certificate of analysis on the lot. A serious facility has one.
The honest answer is that a well-run compounding pharmacy is a serious operation and that the variance across facilities is wide.
Beyond-use dates on compounded sterile preparations are set by standards that depend on the preparation environment and are much shorter than a manufactured product's shelf life.
Specifically, regulators generally prohibit compounding what is essentially a copy of a commercially available product, with a shortage listing being the usual exception that permits it temporarily.
Compounding is defined in regulation as preparation for an individual patient under prescription and is distinguished from manufacturing by scale and by the patient-specific requirement.
Ask which salt form. A different salt is a different active moiety.
Concretely, this is an area where the legal position and the quality question are separate and both matter.
A compounded preparation has no marketing authorisation, no batch release by a qualified person and no pharmacovigilance obligation attached to it. That is the structural difference from a licensed product.
A compounded preparation is unapproved by definition, which is a statement about the framework rather than about the facility.
Check the beyond-use date and what it was based on.
Answer first: a compounded preparation is made for an individual under a prescription and is not an approved product, so it carries neither the release testing nor the pharmacovigilance of one.
Compounding is the preparation of a medicine for an individual patient in response to a prescription, where an approved product is unsuitable. It sits outside the approval framework by design rather than by omission.
Prohibitions on compounding essential copies of commercially available products are explicit in the relevant regulatory frameworks, with shortage listings as the usual exception.
The caveat is that the legal and regulatory position differs by jurisdiction and nothing here is legal advice.
Compounded means unapproved by definition. That is structural, not pejorative.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.